surmount-1 trial tirzepatide weight loss non-diabetic Was Associated with Improved Health-Related Quality of Life in Adults with Obesity or Overweight and Type 2 Diabetes: Results from the Phase 3 SURMOUNT-2 | Diabetes Therapy Lilly Shows Tirzepatide Superiority in
Pay in 4 interest-free payments of $6.51 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 9 - Oct 14

00656-2/asset/09a3e122-d7af-44ed-abbd-db334fe4ca36/main.assets/gr3.jpg)






.png?w=1280&max-h=720&fit=crop&auto=format)













